CCL5 and hepatocellular carcinoma: In the co‐culture of IR‐LX2 CM‐stimulated THP‐1 CM and IR‐HCC cells, CCL20 neutralising antibody, CCR6 inhibitor or JSH‐23 treatment had no significant effect on CCL5 production (Figure S10C).